Table 3.
Study |
Study design |
Outcome measures | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patients |
ARW (mm) |
Site | Graft/N |
GH (months) |
Implant |
IH (months) |
Prosthetics |
OP (months) |
Implant survival (%) |
GARW (mm)/ VRAA (%) |
BCT | ||||
PO | 6 months | 12 months | |||||||||||||
Mean (SD) | Mean (SD) | Mean (SD) | |||||||||||||
Kloss et al. [29] |
Retrospective study |
21 | NR | NR |
Mandible ramus: 21 |
6 | 21 | 6 | Single-crown | 6 | 100 | 5.6 (1.5) | 5.2 (1.6)/5.3 (6.2) | 5.1 (1.5)/6.3 (6.2) | None |
21 | FDA: 21 | 21 | 5.5 (1.5) | 5.2 (1.4)/4.4 (7.1) | 5.2 (1.4)/4.8 (7.2) |
ARW = alveolar ridge width; BTC = biological and technical complications; FDA = freeze-dried bone allograft; GARW = gain in alveolar ridge width; GH = graft healing time; IH = implant healing time; N = number; NR = not reported; OP = observation period after functional implant loading; PO = postoperative; VRAA = volumetric reduction of the augmented area; SD = standard deviation.